Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2021-09-30 00:00:00 ET · period of report 2021-09-28 · accession 0001209191-21-058249 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | 2021-09-28 | VKTX | Mancini Marianna | COO | A - Grant | $0.00 | +6,667 | 180.4K | +4% | $0 | |
| 2021-09-30 | 2021-09-28 | VKTX | Mancini Marianna | COO | F - Tax | $6.50 | -2,839 | 177.5K | -2% | -$18.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2021-09-28 | A | A | 6,667 | $0.00 | 180,374 | D | — | — | (F1) The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2020, 33.33% of which vested on September 28, 2021 upon the achievement of a non-financial performance goal. (F2) Includes 3,755 shares acquired on May 20, 2021 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock, par value $0.00001 per share | 2021-09-28 | F | D | 2,839 | $6.50 | 177,535 | D | — | — | (F3) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award. |